Decera Clinical Education Medical Specialties Podcast

Key PBC Studies From AASLD 2025 Podcast

support@deceraclinical.com (Nancy Reau MD) — Wed, 24 Dec 2025 16:53:49 +0000

Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice.

Topics covered include:

Treatment Goals
Long-term Data With PPAR Agonists
Investigational Therapies for Pruritus

Presenter:

Nancy Reau, MD
Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois

To download the accompanying slides, visit the program page for this episode:
https://bit.ly/4b2d6YD

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Bringing Obesity Advances to Primary Care: 2025 in Review and a Look Ahead

Mon, 15 Dec 2025 21:32:47 +0000

Listen in as Jay H. Shubrook, DO, FACOFP, FAAFP, and Chrisopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA, discuss the latest advances in caring for patients with overweight or obesity in the primary care setting, including:

The Lancet Commission’s new obesity definitions and diagnostic criteria
Key data on incretin-based antiobesity medications like semaglutide and tirzepatide
Best practices for patient discussions
Strategies for incorporating new evidence in your primary care practice

Presenters
Jay H. Shubrook, DO, FACOFP, FAAFP
Professor and Diabetologist
Department of Clinical Sciences and Community Health
Touro University California College of Osteopathic Medicine
Vallejo, California

Christopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA
Bariatric Services Medical Director, Ascension Wisconsin
Obesity Medicine Director, Ascension Columbia St Mary’s Bariatric Center
Trustee, Obesity Medicine Association
Adjunct Assistant Professor of Pediatrics
Medical College of Wisconsin
Milwaukee, Wisconsin

Link to full program:
https://bit.ly/4rG7QQp

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Setting Our Sights on Symptom Management: Raising the Bar in PBC Management Podcast

Thu, 11 Dec 2025 22:28:11 +0000

Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help.

Topics covered include:

Mechanisms of pruritus and fatigue in PBC
Nonpharmacologic treatment options
An overview of clinical trial data supporting second-line agents for symptom management:
Bezafibrate
Elafibranor
Seladelpar
Investigational agents:
Volixibat
Linerixibat
Setanaxib

This episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode:
https://bit.ly/44ZJ5os

Presenters:
Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD,
MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Second-line Agents for Achieving Treatment Goals: Raising the Bar in PBC Management Podcast

Thu, 11 Dec 2025 16:21:29 +0000

New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals.

Topics covered include:

Available agents for second-line treatment of PBC
An overview of clinical trial data supporting second-line agents:
Obeticholic acid (OCA)
Bezafibrate
Elafibranor
Seladelpar

This episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/48MEc3r

Presenters:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD, MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Defining Our Treatment Goals: Raising the Bar in PBC Management Podcast

Wed, 10 Dec 2025 20:34:25 +0000

Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include:

How and when to assess treatment response
Risk factors in PBC
Biochemical treatment response and fibrosis stage as predictors of transplant-free survival
Dynamics of liver stiffness measurements and clinical outcomes in PBC
The importance of bilirubin and alkaline phosphatase normalization

This episode is the first of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os

Presenters:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Gaps and Unmet Needs in PBC Care

support@deceraclinical.com (Stuart C. Gordon MD FAASLD, Alan Bonder MD AGAF) — Fri, 21 Nov 2025 20:27:03 +0000

Join expert faculty, Dr Alan Bonder and Dr Stuart Gordon, to learn more about key gaps in PBC management and how these shortfalls can be addressed through identification of appropriate biochemical goals, proper assessment and management of PBC symptoms, and current second-line therapies.

Presenters:

Alan Bonder, MD, AGAF

Associate Professor of Medicine
Medical Director of Liver Transplant
Beth Israel Deaconess Medical Center
Department of Gastroenterology
Harvard Medical School
Boston, Massachusetts

Stuart C. Gordon, MD, FAASLD

Professor of Medicine
Wayne State University School of Medicine
Professor of Medicine
Michigan State University College of Medicine
Henry Ford Health
Detroit, Michigan

Link to full program:
https://bit.ly/3M29pI1

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Patient Perspectives on New Developments in PBC: Individualizing Patient Care Podcast

support@deceraclinical.com (Maria G. Morais RN) — Mon, 20 Oct 2025 14:17:19 +0000

Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include:

The Canadian PBC Society Survey: Comorbidities and Treatment Goals
Defining and Achieving Goal-Driven Care for PBC
Recent Advances in PBC Management
Newer Agents for Second-line Treatment of PBC

Presenters:

Maria G. Morais, RN
PBC Transplant Patient
VP Patient Advocacy
Canadian PBC Society
Toronto, Canada

Link to full program:
https://bit.ly/44ySoL3

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Keeping Up With New Developments in PBC

support@deceraclinical.com (Christopher L. Bowlus MD, Sonal Kumar MD MPH) — Fri, 17 Oct 2025 17:02:04 +0000

Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice.

Topics covered include:

Methods of Assessing PBC Disease Progression
Newer Agents for Second-line Treatment of PBC
Prioritizing Symptom Management and Quality of Life With PBC Treatment

Presenters:

Christopher L. Bowlus, MD
Lena Valenta Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Sonal Kumar, MD, MPH
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Weill Cornell Medical College
New York, New York

Link to full program:
https://bit.ly/43nHx6U

Get access to all of our new podcasts by subscribing to the CCO Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Conversations in Chronic Cough: A Pulmonologist’s Perspective

support@deceraclinical.com (Peter Dicpinigaitis MD) — Tue, 9 Sep 2025 19:01:59 +0000

Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies.

Presenter
Peter Dicpinigaitis, MD
Professor of Medicine
Albert Einstein College of Medicine
Division of Critical Care Medicine
Montefiore Medical Center
Director, Montefiore Cough Center
Bronx, New York

Link to full program:
https://bit.ly/4kweynG

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Conversations in Chronic Cough: An Otolaryngologist’s Perspective

support@deceraclinical.com (Michael S Benninger MD) — Fri, 11 Jul 2025 04:00:00 +0000

Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case.

Presenter
Michael S. Benninger, MD
Professor of Otolaryngology-Head and Neck Surgery
Lerner College of Medicine
The Cleveland Clinic
President, International Association of Phonosurgery
Cleveland, Ohio

Link to full program:
https://bit.ly/4kweynG

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Quality Improvement in Obesity Care: How to Integrate Comprehensive Diabetes Management

support@deceraclinical.com (Colten Bracken MD FAAFP, Joseph Kim MD MPH MBA) — Thu, 10 Jul 2025 19:26:33 +0000

Listen in as Joseph Kim, MD, MPH, MBA, and Colten Bracken, MD, FAAFP, discuss how to integrate comprehensive diabetes management to improve the quality of their obesity care delivery, including:

Documenting obesity as a diagnosis for patients with diabetes when appropriate
Streamlining processes to ensure patients return for follow-up
Dedicating a care manager to initiate patient outreach
Implementing pharmacotherapy strategies to help patients control their A1C and achieve weight loss simultaneously.

Presenters

Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Colten Bracken, MD, FAAFP
Board of Directors for RHAU & UAFP
Owner/Medical Director
Main Street Family Medicine, PLLC
Enterprise, Utah

Link to full program:
https://bit.ly/3IBFZi5

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Key PBC Studies From EASL and DDW 2025

support@deceraclinical.com (Palak Trivedi BSc MBBS PhD MRCP ESEGH) — Mon, 7 Jul 2025 17:47:44 +0000

In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include:

Steatotic liver disease and PBC
Vibration-controlled transient elastography (VCTE) and discordant biochemical responses in PBC
PPAR agonists and IBATs for PBC treatment

Presenter:

Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH
Associate Professor
NIHR Birmingham BRC
University of Birmingham
Consultant Hepatologist, Liver Unit
University Hospitals Birmingham
Birmingham, United Kingdom

Link to full program:
https://bit.ly/44ySoL3

Follow along with the slides:
https://bit.ly/3IvwQrj

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Evidence-Based Care in Atopic Dermatitis: Practical Considerations for IL-13 Inhibitors for Moderate to Severe Disease

support@deceraclinical.com (Daniel C. Butler MD, Shawn G. Kwatra MD) — Wed, 25 Jun 2025 13:42:10 +0000

In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including:

Patient candidacy considerations
Treatment advancement strategies that go beyond topical therapies
The importance of patient-centered care that address patients’ fears and needs
A detailed patient case to highlight take home points

Presenter

Daniel C. Butler, MD
Assistant Dean Student Affairs
University of Arizona College of Medicine – Tucson
Tucson, Arizona

Shawn G. Kwatra, MD
Dr. Joseph W. Burnett Endowed Professor and Chair
Department of Dermatology
University of Maryland School of Medicine
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Evidence-Based Care in Atopic Dermatitis: IL-13 Inhibitors to Treat Moderate to Severe Disease

Wed, 25 Jun 2025 13:38:49 +0000

In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including:

The available biologic therapies that specifically target IL-13
Where these agents fall in the 2024 American Academy of Dermatology treatment algorithm
How these agents compare to other AD therapies like topical corticosteroids and oral JAK inhibitors
A detailed patient case to highlight take home points

Presenter

Andrew F. Alexis, MD, MPH
Professor of Clinical Dermatology
Weill Cornell Medical College
New York, New York

Daniel C. Butler, MD
Assistant Dean Student Affairs
University of Arizona College of Medicine – Tucson
Tucson, Arizona

Shawn G. Kwatra, MD
Dr. Joseph W. Burnett Endowed Professor and Chair
Department of Dermatology
University of Maryland School of Medicine
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Quality Improvement in Obesity Care: How to Manage Prior Authorizations for Antiobesity Medications

Tue, 24 Jun 2025 19:21:39 +0000

Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including:

The information to collect during patient visits
The available resources to help you submit prior authorizations
The supporting documents that are often necessary to accompany prior authorizations
How to address denials and appeals
When to access manufacturer-based or foundation-based financial assistance

Presenters
Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Manish Shah, MD
Clinical Associate Faculty MS1 Preceptor
University of Florida College of Medicine
Gainesville, Florida

Martha Grugel, MA
Medical Assistant
Wesley Chapel, Florida

Link to full program:
https://bit.ly/45P0v8z

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

support@deceraclinical.com (Andrew F. Alexis MD MPH, Daniel C. Butler MD) — Tue, 24 Jun 2025 16:07:24 +0000

In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including:

Contributors to epidermal barrier dysfunction (eg, environmental triggers)
IL-13 as a key cytokine in AD pathogenesis
Targeted AD therapies that inhibit IL-13
A detailed patient case to highlight take-home points

Presenter

Andrew F. Alexis, MD, MPH
Professor of Clinical Dermatology
Weill Cornell Medical College
New York, New York

Daniel C. Butler, MD
Assistant Dean Student Affairs
University of Arizona College of Medicine – Tucson
Tucson, Arizona

Program page:
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Innovations in NCFBE: Latest Advances and Personalization of Treatment

support@deceraclinical.com (Anne E. O’Donnell MD) — Fri, 20 Jun 2025 19:00:00 +0000

In this podcast, Anne E. O’Donnell, MD, discusses the latest advances and treatment strategies for patients with non–cystic fibrosis bronchiectasis (NCFBE), including:

Airway clearance as a foundation of NCFBE management
Strategies to address inflammation and exacerbations
Emerging therapies in clinical development
How to individualize treatment to NCFBE phenotypes and endotypes

Presenter
Anne E. O’Donnell, MD
Professor of Medicine
The Nehemiah and Naomi Cohen Chair in Pulmonology Disease Research
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
Georgetown University Medical Center
Washington, DC

Program page:
https://bit.ly/4mZbYsm

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Heart Failure and MRAs: Diving Deep Into the Pivotal FINEARTS-HF Trial

support@deceraclinical.com (Ty J. Gluckman MD MHA) — Wed, 18 Jun 2025 19:31:12 +0000

In this podcast, Ty J. Gluckman, MD, MHA, discusses the pivotal phase III FINEARTS-HF trial and how the treatment landscape is evolving for patients with heart failure (HF) with mildly reduced or preserved ejection fraction, including:

The emerging role of mineralocorticoid receptor antagonists in HF care
Finerenone’s efficacy in reducing composite cardiovascular death and worsening HF events
Why safety must be monitored, especially considering hyperkalemia risk
Where HF guideline recommendations lack compared with the current evidence

Presenter

Ty J. Gluckman, MD, MHA
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS)
Providence Heart Institute
Providence Health System
Portland, Oregon

Program page:
https://bit.ly/448XcH0

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Innovations in NCFBE: Understanding the Patient Burden and Best Practices in Diagnostics

Wed, 18 Jun 2025 18:20:25 +0000

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:

The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)
Cough as the most significant symptom and burden
Imaging bronchiectasis with classic and inflammatory findings
Differentiating the causes of NCFBE to inform patient care

Presenters

Brett M. Elicker, MD
Professor of Clinical Radiology
Chief, Cardiothoracic Imaging Division
Department of Radiology & Biomedical Imaging
University of California, San Francisco
San Francisco, California

David E. Griffith, MD, ATSF, FACCP, FRSM
Professor of Medicine
Division of Mycobacterial and Respiratory Diseases
Department of Medicine
National Jewish Health
Denver, Colorado

Program page:
https://bit.ly/4mZbYsm

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Quality Improvement in Obesity Care: How to Develop Patient-Centered and Tailored Treatment Plans

support@deceraclinical.com (Joseph Kim MD MPH MBA) — Fri, 13 Jun 2025 14:43:16 +0000

Listen in as Joseph Kim, MD, MPH, MBA, interviews Natalie, Orbach, PA-C, to learn about how she implemented patient-centered and individualized treatment plans to improve obesity care at her practice, including

Discussing weight and how nutrition, physical activity, mental health, and pharmacotherapy strategies can help
Meeting patients where they are at and offering slow, incremental changes that support long-term outcomes
Referring patients to community resources and other professionals as need
Sharing lessons learned for those interested in implementing similar strategies in their practice

Presenter

Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Natalie Orbach, PA-C
Physician Assistant
Feirtag & Ramos, PA
Lutherville, Maryland

Link to full program:
https://bit.ly/45P0v8z

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Conversations in Chronic Cough: An Allergist’s Perspective

support@deceraclinical.com (Michael S. Blaiss MD) — Wed, 28 May 2025 14:50:33 +0000

Listen as Michael S. Blaiss, MD provides case-based perspectives on chronic cough recognition, burden, management, and pathophysiology and describes the evolving treatment landscape for refractory chronic cough.

Presenter
Michael S. Blaiss, MD
Clinical Professor of Pediatrics
Division of Allergy-Immunology
Medical College of Georgia at Augusta University
Augusta, Georgia

Link to full program:
https://bit.ly/4kweynG

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Expert Guidance in Alpha-1 Antitrypsin Deficiency: Why Early Detection and Multidisciplinary Management Are Key

Fri, 9 May 2025 17:20:51 +0000

Listen in as Paula Henao, MD; Rohit Loomba, MD, MHSc; Cheryl Pirozzi, MD, MS; and Corinne Young, NP, FCCP, discuss their screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including:

Why early detection is key for improving patient outcomes
How to monitor through use of noninvasive imaging and biopsy per guideline recommendations
How to coordinate patient care to provide much-needed multidisciplinary care
What therapies in the pipeline could transform the treatment landscape for this genetic disease

Presenters

Paula Henao, MD
Assistant Professor of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Penn State Hershey Medical Center
Hershey, Pennsylvania

Rohit Loomba, MD, MHSc
Professor of Medicine
Chief, Division of Gastroenterology and Hepatology
Director, MASLD Research Center
University of California, San Diego
San Diego, California

Cheryl Pirozzi, MD, MS
Associate Professor of Internal Medicine
Division of Pulmonary and Critical Care Medicine
University of Utah
Salt Lake City, Utah

Corinne Young, NP, FCCP
President/Founder
Association of Pulmonary Advanced Practice Providers
Colorado Springs, Colorado

Link to full program:
https://bit.ly/4dgCRnq

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Quality Improvement in Obesity Care: How to Implement Virtual Support Groups

support@deceraclinical.com (Joseph Kim MD MPH MBA, Sajal Desai MD DABOM) — Wed, 7 May 2025 20:10:10 +0000

Listen in as Joseph Kim, MD, MPH, MBA, interviews Sejal Desai, MD, DABOM, to learn about how she implemented virtual support groups to improve obesity care at her practice, including:

Dedicating 5 support groups with chat features to obesity-specific topics (eg, sleep, nonscale wins)
Moderating these chats to ensure no misinformation is shared and a positive, safe space is maintained
Expanding to include other virtual options that allow patients to engage more in their care
Utilizing free and subscription-based services to aid in marketing efforts
Sharing lessons learned for those interested in implementing similar virtual options for their patients

Presenters

Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Sejal Desai, MD, DABOM
Board-Certified Obesity Medicine Physician
Owner & Medical Director
Tula Medical Weight Loss & Wellness
Katy, Texas

Link to full program:
https://clinicaloptions.com/content/qi-resource-hub

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Quality Improvement in Obesity Care: How to Implement Documentation Shortcuts

support@deceraclinical.com (Joseph Kim MD MPH MBA, Sophia Kwon MD) — Fri, 11 Apr 2025 18:46:31 +0000

Listen in as Joseph Kim, MD, MPH, MBA, interviews Sophia Kwon, MD, to learn about how she implemented a documentation shortcut at her institution to improve obesity care, including:

Creating an obesity checklist within the electronic health record
Training staff to correctly use this checklist and broach obesity topics with patients
Garnering feedback to ensure this checklist did not add to note fatigue or burnout among staff
Sharing lessons learned for others interested in implementing a similar documentation shortcut

Presenter
Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Sophia Kwon, MD
Internal Medicine Attending
Riverside University Health System Attending
Loma Linda University Health Associate Faculty
Loma Linda, California

Link to full program:
https://clinicaloptions.com/content/qi-resource-hub

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Partnering With Patients for PBC Care: Actionable Strategies for HCPs

Tue, 1 Apr 2025 04:00:00 +0000

In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss challenges related to the diagnosis and management of primary biliary cholangitis (PBC) to provide actionable strategies for healthcare professionals to incorporate into patient care, including:

Disease concerns and frequently asked questions from a patient perspective
Managing symptoms
Treatment options and supportive care
Importance of awareness and education

Presenters:
Gideon Hirschfield, MA, MB BChir, FRCP, PhD
Lily and Terry Horner Chair in Autoimmune Liver Disease Research
Professor, Division of Gastroenterology and Hepatology
University of Toronto
Director, The Autoimmune and Rare Liver Disease Programme
Director, Francis Family Liver Clinic
Toronto General Hospital, University Health Network
Ontario, Canada

Jess N. Schnur, BSN-RN
National PBC Patient Advocate
American Liver Foundation
Donation Support Services Coordinator
Lifeline of Ohio
Columbus, Ohio

To learn more, see the program Hear Me: Patient Perspectives on PBC

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Debating the Role of ALP Normalization in PBC: Curbside Consults Podcast

support@deceraclinical.com (Stuart C. Gordon MD, Nancy Reau MD) — Mon, 24 Mar 2025 15:59:28 +0000

In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau, use an illustrative patient case to explore the roles of ALP and other biochemical markers in PBC management, and explain what to expect from treatment. Topics covered include:

How baseline ALP can affect ALP normalization after second-line treatment with elafibranor and seladelpar
Potential outcomes if ALP normalization cannot be achieved
The importance of managing fatigue, pruritus, and sleep disturbances independently of the biochemical response

Presenters:

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Nancy Reau, MD
Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois

To learn more about PBC management, check out our program, Curbside Consults: Expert Insights on Challenges in PBC Management.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Managing PBC Therapy for Patients With Cirrhosis: Curbside Consults Podcast

support@deceraclinical.com (Stuart C. Gordon MD, Nancy Reau MD) — Tue, 18 Mar 2025 20:11:27 +0000

In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau discuss an illustrative patient case to demonstrate how they individualize primary biliary cholangitis (PBC) therapy for patients with cirrhosis. Topics covered include:

AASLD guideline recommendations for second-line therapy for PBC
Considerations when using newer agents for second-line treatment of PBC in patients with cirrhosis: elafibranor and seladelpar

Presenters:

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

To learn more about PBC management, check out our program,
Curbside Consults: Expert Insights on Challenges in PBC Management.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Evaluating and Managing PBC Symptoms: Curbside Consults Podcast

support@deceraclinical.com (Alan Bonder MD AGAF, Aparna Goel MD) — Mon, 24 Feb 2025 18:45:42 +0000

In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss how they assess the symptoms of primary biliary cholangitis (PBC) and explore how new therapeutic agents may help alleviate symptom burden. Topics include:

Strategies and tools for assessing pruritus
Nonpharmacologic and pharmacologic management of pruritus
Second-line agents and their impact on pruritus
Investigational treatments for pruritus

Presenters:

Alan Bonder, MD, AGAF
Associate Professor of Medicine
Medical Director of Liver Transplant
Department of Gastroenterology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Aparna Goel, MD
Associate Clinical Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Content based on an online CME program supported by independent educational grants from Gilead Sciences, Inc., and Ipsen Biopharmaceuticals, Inc.

To learn more about PBC management, check out our program, Curbside Consults: Expert Insights on Challenges in PBC Management.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Defining Nonresponse to PBC Treatment: Curbside Consults Podcast

support@deceraclinical.com (Alan Bonder MD AGAF, Aparna Goel MD) — Mon, 24 Feb 2025 18:29:42 +0000

How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including:

How and when to measure treatment response
Evidence-based goals of therapy
Considerations for second-line treatment
New agents for second-line treatment: PPAR agonists

Presenters:

Aparna Goel, MD
Associate Clinical Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Content based on an online CME program supported by independent educational grants from Gilead Sciences, Inc., and Ipsen Biopharmaceuticals, Inc.

To learn more about PBC management, check out our program,
Curbside Consults: Expert Insights on Challenges in PBC Management.

Supported by educational grants from Gilead Sciences, Inc. and Ipsen Biopharmaceuticals, Inc

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

PBC Perspectives: A Patient and HCP in Conversation

support@deceraclinical.com (Sonal Kumar MD MPH, Maria Morais RN) — Thu, 13 Feb 2025 19:52:08 +0000

In this podcast, Sonal Kumar, MD, MPH, meets with patient advocate Maria Morais to discuss actionable steps that healthcare providers can incorporate into the care of people with primary biliary cholangitis (PBC). Listen as they discuss:

The chronic nature of PBC
Going beyond biochemical markers to assess and address symptoms such as fatigue and pruritus
The importance of referral to patient support groups

Presenters:

Sonal Kumar, MD, MPH
Assistant Professor of Medicine
Director, General Gastroenterology and Hepatology
Weill Cornell Medical College
New York, New York

Maria G. Morais, RN
VP Patient Advocacy
Canadian PBC Society
Toronto, Canada

To learn more, see the program Hear Me: Patient Perspectives on PBC

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Expert Guidance on Managing Axial Spondyloarthritis and Psoriatic Arthritis to Improve Patient Outcomes and Quality of Life

support@deceraclinical.com (Alexis Ogdie MD MSCE, Julia Swafford PA-C DFAAPA) — Wed, 29 Jan 2025 21:09:52 +0000

Listen in as rheumatology experts Alexis Ogdie, MD, MSCE, and Julia Swafford, PA-C, DFAAPA, discuss emerging therapies and strategies in managing patients with axial spondyloarthritis or psoriatic arthritis, including:

The current treatment landscape (eg, small molecules, biologics)
Risk factors to consider when prescribing JAK inhibitors
Key considerations regarding comorbidities, especially in addressing depression, anxiety, or social ideation
Nonpharmacologic options to improve treatment outcomes
Shared decision-making strategies to enhance patients’ investment in their care

Presenter:

Alexis Ogdie, MD, MSCE
Director, Penn Psoriatic Arthritis and Spondylarthritis Program
Director, Penn Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania
Philadelphia, Pennsylvania

Julia Swafford, PA-C, DFAAPA
President of SPAR
Bronson Battle Creek Rheumatology Specialists
Battle Creek, Michigan

Link to full program:
https://bit.ly/4gkTzSv

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Key PBC Studies From AASLD 2024

support@deceraclinical.com (Sonal Kumar MD MPH) — Tue, 7 Jan 2025 19:15:00 +0000

In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including:

ELATIVE, a phase III trial of elafibranor for PBC
RESPONSE, a phase III trial of seladelpar for PBC
ASSURE, another phase III trial of seladelpar for PBC

Presenter:
Sonal Kumar, MD, MPH
Director, Clinical Gastroenterology and Hepatology
Assistant Professor of Medicine
Weill Cornell Medical College
New York, New York

Link to full program:
https://bit.ly/41tvSDu

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Emerging Therapies for Pruritus in PBC

Wed, 18 Dec 2024 17:04:56 +0000

Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients’ quality of life.

Listen as they discuss:

Gaps in current management
Patient perspectives: why we should not dismiss itching as an underlying psychologic problem
PPAR agonists and how they affect pruritus
BEZURSO and FITCH
ELATIVE
ENHANCE and RESPONSE
IBATs (inhibitors of bile acid transport)
GLIMMER
Common questions

Presenters:

Marlyn J. Mayo, MD
Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Pam Rivard, RN
Person living with PBC

Link to full program:
https://bit.ly/3Dnfb2E

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Clinical Management of Pruritus in PBC

Wed, 18 Dec 2024 16:18:01 +0000

Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including:

Pruritus assessment tools
Optimal use of tools, including frequency of assessment
Current management of pruritus
Nonpharmacologic interventions
Pharmacologic agents
Strategies to optimize assessment and management of pruritus
Collaborative care
Development of a treatment plan
Ongoing assessment and adjustment of therapy
Resources and support for patients

Presenters:

Marlyn J. Mayo, MD
Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Pam Rivard, RN
Person living with PBC

Link to full program:
https://bit.ly/3Dnfb2E

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Living With Pruritus in PBC: A Patient Perspective

Wed, 18 Dec 2024 15:03:23 +0000

In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient’s perspective.

Presenters:

Marlyn J. Mayo, MD
Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Pam Rivard, RN
Person living with PBC

Link to full program:
https://bit.ly/4gDGDaB

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Recent Advances in PBC Management

support@deceraclinical.com (Christopher L. Bowlus MD) — Thu, 12 Dec 2024 21:48:38 +0000

In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including:

Treatment goals
Use of PPAR agonists for the treatment of PBC
Clinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO)

Presenter:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
University of California Davis School of Medicine
Sacramento, California

Link to full program:
https://bit.ly/41tvSDu

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Navigating Sjogren's Syndrome: Guiding Patients in Their Care Journey

support@deceraclinical.com (Elizabeth Kircher DNP, R. Hal Scofield MD) — Mon, 4 Nov 2024 22:00:00 +0000

Listen as Elizabeth Kircher, DNP, and R. Hal Scofield, MD, discuss best practice approaches for the treatment of Sjögren’s syndrome and what’s on the horizon for future therapeutic options.

Topics include:

Challenges in Sjogren’s Syndrome Diagnosis and Patient Understanding: Difficulties in explaining Sjogren’s syndrome diagnosis to patients unfamiliar with it and challenges in addressing the disease’s varied symptoms
Patient Education and Communication: Strategies to prevent overwhelming patients during early visits and effective ways to address misconceptions
Diagnostic Challenges and Misunderstandings: Differences between clinical and research criteria for diagnosis and the importance of understanding each
Use of Ultrasound and Biopsy in Diagnosis: Benefits and limitations of ultrasound and biopsies in diagnosing Sjogren’s syndrome
Multidisciplinary Care Barriers: Challenges in coordinating care among specialists such as ophthalmologists, dentists, and rheumatologists
Symptomatic vs Disease-Modifying Treatments: Strategies for managing symptoms vs addressing the underlying disease with medications
Long-term Medication and Risks: Considerations when prescribing long-term medications and immunosuppressive therapies
Research and Emerging Therapies: Developments in Sjogren’s syndrome research, including promising medications in clinical trials
Guideline Development and Patient Reassurance: The role of professional guidelines in shaping care and providing patients with reassurance
Polypharmacy and Medication Reconciliation: The importance of pharmacist involvement in managing complex medication regimens for older patients

Faculty:

Elizabeth Kircher, DNP

R. Hal Scofield, MD
Member/Professor, Arthritis & Clinical Immunology
Oklahoma Medical Research Foundation
Professor, Department of Medicine, College of Medicine
University of Oklahoma Health Sciences Center
Associate Chief of Staff for Research
Oklahoma City US Department of Veterans Affairs Medical Center
Oklahoma City, Oklahoma

Link to full program:
https://bit.ly/3YKpsOE

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Paradigm Shifting Updates in IgAN: Expert Faculty Discussions of Recent Breakthroughs

support@deceraclinical.com (Andrew Bomback MD PhD, Pietro Canetta MD MS) — Mon, 9 Sep 2024 17:10:49 +0000

In this CCO Nephrology podcast episode, hear from nephrologists Pietro Canetta, MD, MS, and Andy Bomback, MD, PhD, experts in clinical management and research on glomerular diseases as they discuss key updates in managing IgAN. Faculty highlight the importance of a comprehensive supportive care regimen to protect patients’ kidneys and prevent progression of disease. In addition, they review the merits and place in therapy of novel and emerging therapies.

Topics include:

Supportive care as the foundation of IgAN management
Place in therapy for new and emerging agents
- Targeted-release formulation of budesonide
- Endothelin receptor antagonists (eg, sparsentan)
- Factor B inhibitors (eg, iptacopan)
The role of clinical trial involvement

Learn more about IgA nephropathy with educational activities and resources here:

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Expert Discussions: Novel Agents Targeting Residual Inflammatory Risk in ASCVD and CKD

Mon, 26 Aug 2024 19:12:06 +0000

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they discuss new and emerging therapies designed to target residual inflammatory risk associated with ASCVD and CKD.  

 Episode outline:  

Colchicine: inhibition of NLRP3 inflammasome assembly/activation
Canakinumab (anti–IL-1β monoclonal antibody)
Ziltivekimab (anti–IL-6 monoclonal antibody)
Other emerging targets/therapies

To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Expert Discussions on Residual Systemic Inflammation in ASCVD and CKD

Mon, 26 Aug 2024 18:42:52 +0000

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore new and emerging strategies to target residual risk associated with systemic inflammation in patients with ASCVD and CKD.  

 Episode outline:  

The relationship among systemic inflammation, ASCVD, and CKD
The role of cardiologists and nephrologists in screening and mitigating systemic inflammation

To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD

Mon, 26 Aug 2024 18:12:27 +0000

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD.  

 Episode outline:  

Moving beyond lipid lowering to address residual inflammatory risk
Novel anti-inflammatory targets for ASCVD

To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Navigating IgA Nephropathy: Insights From a Patient With Lived Experience

support@deceraclinical.com (Pietro Canetta MD, Kelly B. Chen BSN MSN NP) — Thu, 11 Jul 2024 20:19:36 +0000

In this CCO Nephrology podcast episode, hear from Kelly Chen, a nephrology nurse practitioner and patient living with IgA nephropathy, as she discusses her experiences with Dr Pietro Canetta, Associate Professor of Medicine at Columbia University and expert in glomerular diseases.

Episode outline:

Seeking and obtaining an IgAN diagnosis
Patient self-advocacy
Individualizing IgAN treatment plans
Clinical trial involvement
Burdens of IgAN: physical, emotional, social, and beyond

To learn more about IgA nephropathy, find more educational activities and resources with the links below:

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

How to Implement Earlier Hepatitis B Treatment

Tue, 26 Mar 2024 18:30:31 +0000

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include:

Patient subgroups to consider for treatment outside guideline criteria
Adverse event and cost-effectiveness considerations
Integration of patient perspectives in wider treatment

Presenters:

Mark S. Sulkowski, MD, FIDSA, FAASLD
Professor of Medicine
Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Tatyana Kushner, MD, MSCE
Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Paul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Jacki Chen, PhD
Patient Advocate

Link to full program:
https://bit.ly/3TuqFHI

Link to the slides:
https://bit.ly/4a60GM4

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Art of Multidisciplinary Care for Patients With Metabolic Dysfunction–Associated Steatohepatitis

support@deceraclinical.com (Arun B. Jesudian MD, Mazen Noureddin MD MHSc) — Wed, 13 Mar 2024 16:50:05 +0000

In this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies.

Presenters:

Arun B. Jesudian, MD
Associate Professor of Clinical Medicine
Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York

Mazen Noureddin, MD, MHSc
Professor of Medicine
Houston Methodist Hospital
Director
Houston Research Institute
Houston, Texas

Content based on an online CME program supported by independent educational grants from Novo Nordisk.

To view the full program on “Clinical Pathways: Multidisciplinary Approach to Managing Metabolic Dysfunction‒Associated Steatohepatitis,” including 4 CME/CE-certified text modules with accompanying slidesets, 4 ClincalThought commentaries, and a downloadable infographic resource on the AGA MASLD MASH Clinical Care Pathway, visit clinicaloptions.com or click on the link below.

Link to full program:
https://bit.ly/3Tyu7At

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients

support@deceraclinical.com (Jennifer Green MD, Carol Hatch Wysham MD) — Mon, 12 Feb 2024 15:09:43 +0000

In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes:

Beneficial effects beyond glycemic control
Adverse events and how to manage them
Non- or partial responders and the importance of setting expectations with patients
Weight rebound when discontinuing therapy
Medication access issues related to cost and drug availability

Presenters:

Jennifer Green, MD
Professor of Medicine
Division of Endocrinology and Duke Clinical Research Institute
Duke University School of Medicine
Durham, North Carolina

Carol Hatch Wysham, MD
Clinical Professor of Medicine
Clinical Endocrinologist
MultiCare/Rockwood Clinic
Spokane, Washington

Link to online program:
https://bit.ly/48b6XnW

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

How to Implement Earlier Hepatitis B and Hepatitis Delta Screening

support@deceraclinical.com (Decera Clinical Education) — Fri, 22 Dec 2023 05:00:00 +0000

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:

Updated CDC recommendations for one-time universal screening for HBV
Addressing patient-, provider-, and system-level barriers to universal HBV screening
Best practices for implementation of HDV screening

Presenters:

Douglas Dieterich, MD
Director, Institute for Liver Medicine

Professor of Medicine

Division of Liver Diseases

Mount Sinai School of Medicine

New York, New York

Camilla S. Graham, MD, MPH
Co-Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Robert Wong, MD, MS
Clinical Associate Professor
Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Palo Alto, California

Link to full program:
https://bit.ly/3TuqFHI

Link to the slides:
https://bit.ly/4atS42z

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Finding Your Friendtors: Mentors, Sponsors, and Allies

support@deceraclinical.com (Aline Charabaty, Marla Dubinsky) — Mon, 25 Sep 2023 20:30:00 +0000

In this podcast episode, Aline Charabaty, MD, AGAF, FACG, and Marla Dubinsky, MD, discuss how women in gastroenterology (GI) can find their “friendtors” and build a strong network of mentors, sponsors, and allies. Although there may be many barriers for women in the GI medicine specialty, these experienced leaders have useful tips to help emerging healthcare professionals avoid internalizing these challenges and strategically focus on accomplishing their goals.

Presenters:

Dr Aline Charabaty is an Assistant Professor of Medicine at Johns Hopkins School of Medicine, the Clinical Director of the IBD Centre at Johns Hopkins Sibley Memorial Hospital in Washington, DC, and the Co-Founder of Scrubs & Heels.

Aline Charabaty, MD, AGAF, FACG: consultant/advisor/speaker: AbbVie, Bristol Myers Squibb, Janssen, Lilly, Pfizer, Takeda.

Dr Marla Dubinsky is a Professor of Pediatrics and Medicine at Mount Sinai in New York, Chief of Division of Pediatric GI and Nutrition at Mount Sinai Kravis Children's Hospital, and the Co-Director of the Susan and Leonard Feinstein IBD Clinical Centre. Dr Dubinsky is also the Director of the Marie and Barry Lipman IBD Preconception and Pregnancy Clinic. She is also an innovator and the Co-Founder of Trellus Health, providing personalized resilience coaching for people living with IBD. She received the Sherman Prize in 2022, which recognized her outstanding achievement in the field of IBD. In addition, she served as the Co-Chair for our inaugural Scrubs & Heels Leadership Summit in 2022.

Marla Dubinsky, MD: consultant/advisor/speaker: AbbVie, Abivax, AstraZeneca, Bristol Myers Squibb, Janssen, Lilly, Merck, Pfizer, Prometheus Biosciences, Takeda.

Episode outline:

Overview of barriers faced by women in GI
Impact of failing to adequately address these barriers
Defining the roles of mentors, sponsors, and allies
Important qualities of mentors, sponsors, and allies
Role models vs peer mentors

Other program activities:

Full Program: Equipped and Empowered: Thriving as Women in GI
Podcast 2: Embracing Your Value: Tools and Strategies for Optimizing Professional Growth and Development
Podcast 3: Being Your Full Self: Pursuing Work–Life Balance
ClinicalThought: Expert Commentary on Thriving as Women in GI

After selecting the “Continue to Post Test” button:

To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select 1 best answer for each question. When you have completed all the questions, press the "Continue" button at the bottom

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Being Your Full Self: Pursuing Work–Life Balance

Mon, 25 Sep 2023 20:30:00 +0000

In this podcast episode, Aline Charabaty, MD, AGAF, FACG, and Christina Tennyson, MD, DipABLM, discuss how women in gastroenterology (GI) can fight burnout and establish a work–life balance that meets their needs. Tune in to learn how to say no, about the importance of saying yes to meaningful things that will advance your career and bring you joy, and get essential tips for well-rounded and ongoing self-care.

Presenters:
Dr Aline Charabaty is an Assistant Professor of Medicine at Johns Hopkins School of Medicine, the Clinical Director of the IBD Centre at Johns Hopkins Sibley Memorial Hospital in Washington, DC, and the Co-Founder of Scrubs & Heels.

Aline Charabaty, MD, AGAF, FACG: consultant/advisor/speaker: AbbVie, Bristol Myers Squibb, Janssen, Lilly, Pfizer, Takeda.

Dr Christina Tennyson is a gastroenterologist with expertise and certification in nutrition, lifestyle medicine, and integrative medicine. She started her career in academia at Columbia University in New York before joining the Augusta Health Digestive Wellness program in the Virginia Shenandoah Valley, where she is engaged in a multidisciplinary program that includes culinary medicine classes and farm workshops for patients.

Christina Tennyson, MD, DipABLM, has no relevant financial relationships to disclose.

[Link to: https://scrubsandheels.com/]

Episode outline:

Variables that contribute to burnout
Strategies to protect your time
Vetting collaborative projects
Requesting flexible schedules, part-time work, maternity leave
Charting your own career path
Prioritizing personal time
Preserving friendships, hobbies
Leave work at work

Other program activities:

Full Program: Equipped and Empowered: Thriving as Women in GI https://bit.ly/3Zmqy1I]
Podcast 1: Finding Your Friendtors: Mentors, Sponsors, and Allies https://bit.ly/3LuKzO6
Podcast 2: Embracing Your Value: Tools and Strategies for Optimizing Professional Growth and Development https://bit.ly/3RsFl9i
ClinicalThought: Expert Commentary on Thriving as Women in GI https://bit.ly/48oi5iS

Link to CME: Claim Credit: https://bit.ly/48oi5iS

[After selecting the “Continue to Post Test” button:]

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Embracing Your Value: Tools and Strategies for Optimizing Professional Growth and Development

Mon, 25 Sep 2023 20:30:00 +0000

In this podcast episode, Anita Afzali, MD, MPH, MHCM, FACG, AGAF, and Aja McCutchen, MD, discuss how women in gastroenterology (GI) can embrace and enhance their value. These inspiring GI medicine experts propose a practical formula that involves ongoing, careful self-reflection and asking yourself how your strengths, core values, and interests can be aligned with professional endeavors. In addition, self-advocacy and self-allyship can serve as harmonious tools to drive action and positive change.

Presenters:

Dr Anita Afzali is a Professor of Clinical Medicine, Interim Division Director of the Division of Digestive Diseases, Executive Vice Chair of Medicine in the Department of Internal Medicine, and the Associate Chief Medical Officer of the UC Health system in Cincinnati, Ohio. She is also a Co-Founder of Scrubs & Heels.

Anita Afzali, MD, MPH, MHCM, FACG, AGAF: consultant: AbbVie, Bristol Myers Squibb, Gilead Sciences, Janssen, Lilly, Pfizer, Takeda; provider of non-CME/CE services: AbbVie, Janssen, Pfizer, Takeda.

Dr Aja McCutchen is a Partner and Physician Executive at Atlanta Gastroenterology Associates, a division of United Digestive in Atlanta, Georgia, and served as Co-Chair at the Scrubs & Heels 2023 Leadership Summit.

Aja McCutchen, MD: consultant/advisor/speaker: Eli Lilly, Modify Health, Redhill Biopharm, Sanofi Regeneron, Takeda.

Episode outline:

Understanding and establishing your own market value; bringing that to your own organization
Consequences of being ill-equipped to pursue professional growth and development
Advocating for the value you bring to the profession
Negotiation as a form of self-allyship
Negotiation categories to help support career success and protect work–life balance

Other program activities:

Full Program: Equipped and Empowered: Thriving as Women in GI
Podcast 1: Finding Your Friendtors: Mentors, Sponsors, and Allies
Podcast 3: Being Your Full Self: Pursuing Work–Life Balance
ClinicalThought: Expert Commentary on Thriving as Women in GI

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Addressing Health Disparities in Anemia of Chronic Kidney Disease

support@deceraclinical.com (Santosh Saraf MD, Milda Saunders MD MPH) — Wed, 7 Dec 2022 21:30:00 +0000

This podcast episode is part of a multimedia program discussing the impact of health disparities in anemia of chronic kidney disease (CKD) on patient outcomes. Tune in to hear Santosh Saraf, MD, and Milda Saunders, MD, MPH, highlight mitigation strategies to improve screening and management. The overview will include:

The definition of CKD and the relative prevalence in specific minority groups
How health disparities affect CKD-related clinical and patient outcomes
Appropriate screening techniques to diagnose patients with anemia of CKD
Strategies to address health disparities to improve patient outcomes in the management of anemia of CKD

Presenters:

Santosh Saraf, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Department of Medicine
University of Illinois at Chicago
Chicago, Illinois

Milda Saunders, MD, MPH
Associate Professor of Medicine
Department of Medicine
University of Chicago
Chicago, Illinois

To view other program offerings, including a CE-certified on-demand webcast, a ClinicalThought commentary, and to download slides, visit:
https://bit.ly/3iL07S0

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Key Points in the Management of Lupus and Lupus Nephritis

support@deceraclinical.com (Karen Costenbader MD MPH, Brad Rovin MD) — Mon, 6 Jun 2022 21:05:00 +0000

In this episode, listen as Karen H. Costenbader, MD, MPH, and Brad H. Rovin, MD, answer key questions about identifying patients at high risk for lupus nephritis, whether an elevated serum creatinine always signals lupus nephritis, the safety of newer therapies for lupus in women who are pregnant or breastfeeding, and the possibility of using SGLT2 inhibitors in patients with lupus nephritis.

Presenters:

Karen H. Costenbader, MD, MPH
Professor of Medicine
Department of Medicine
Harvard Medical School
Director, Lupus Program
Division of Rheumatology, Inflammation and Immunity
Brigham and Women’s Hospital
Boston, Massachusetts

Brad H. Rovin, MD
Professor and Director, Division of Nephrology
The Lee A. Hebert Professor of Nephrology
Medical Director, The Ohio State Center for Clinical Research Management
The Ohio State University Wexner Medical Center
Columbus, Ohio

Review the downloadable slidesets at:
https://bit.ly/3mlHOla

Link to full program:
https://bit.ly/3aC2NNL

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Interview with the Experts: Strategies to Overcome SDOH in NVAF Part 2

support@deceraclinical.com (Keith C Ferdinand MD FACC FAHA, David S. Kountz MD) — Fri, 3 Jun 2022 16:45:00 +0000

In this episode, David S. Kountz, MD, discusses with Keith C. Ferdinand MD, FACC, FAHA, a patient case in which health disparities affected NVAF care and provides patient, provider, and health-system level strategies to address these disparities to improve NVAF-related cardiovascular outcomes.

Presenters

Keith C. Ferdinand, MD, FACC, FAHA
Professor of Medicine
Tulane Heart and Vascular Institute
Tulane University School of Medicine
New Orleans, Louisiana

David S. Kountz, MD
Professor of Medicine
Department of Medicine
Hackensack Meridian School of Medicine
Nutley, New Jersey

Link to full program:
https://bit.ly/3MbIfZI

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Interview With the Experts: Strategies to Overcome SDOH in NVAF Part 1

support@deceraclinical.com (Keith C. Ferdinand MD FACC FAHA, David S. Kountz MD) — Fri, 3 Jun 2022 16:40:00 +0000

In this episode, Keith C. Ferdinand MD, FACC, FAHA, discusses with David S. Kountz, MD, a patient case in which health disparities affected NVAF care and provides strategies to address low health literacy and patient access to direct-acting oral anticoagulant to improve NVAF-related cardiovascular outcomes.

Presenters

Keith C. Ferdinand, MD, FACC, FAHA
Professor of Medicine
Tulane Heart and Vascular Institute
Tulane University School of Medicine
New Orleans, Louisiana

David S. Kountz, MD
Professor of Medicine
Department of Medicine
Hackensack Meridian School of Medicine
Nutley, New Jersey

Link to full program:
https://bit.ly/3MbIfZI

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Reducing Disparities in Lupus and Lupus Nephritis Care

support@deceraclinical.com (Karen Costenbader MD MPH, Brad Rovin MD) — Thu, 2 Jun 2022 19:00:00 +0000

In this episode, Karen H. Costenbader, MD, MPH, and Brad H. Rovin, MD, discuss health disparities in systemic lupus erythematosus and lupus nephritis. Topics include:

Disproportionate prevalence among marginalized groups in the United States
Lupus-related social determinants of health
Challenges with medication adherence
Strategies to reduce these disparities

Presenters:

Karen H. Costenbader, MD, MPH
Professor of Medicine
Department of Medicine
Harvard Medical School
Director, Lupus Program
Division of Rheumatology, Inflammation and Immunity
Brigham and Women’s Hospital
Boston, Massachusetts

This episode is part of a larger program titled, “Lupus and Lupus Nephritis: Improving Outcomes and Reducing Disparities.” To access the full program, follow this link:
https://bit.ly/3PWAzNU

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

NVAF Management and Future Directions

Thu, 26 May 2022 16:10:00 +0000

This podcast is the third in a series of 3 featuring an expert multidisciplinary panel of faculty addressing the impact of social determinants of health on NVAF and CV-related outcomes and strategies to overcome these disparities. In this episode, Keith C. Ferdinand, MD, FACC, FAHA, details the effects of SDOH on anticoagulation prescribing in NVAF and provides an overview of areas for future study.

Review the downloadable slideset and the full program at:
https://bit.ly/3yYXP8e

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Strategies to Overcome SDOH in NVAF

Thu, 26 May 2022 16:10:00 +0000

This podcast is the second in a series of 3 featuring an expert multidisciplinary panel of faculty addressing the impact of social determinants of health on NVAF and CV-related outcomes and strategies to overcome these disparities. In this episode, Laura Ross PA-C, CLS, dives deeper into the impacts of SODH on NVAF care and provides strategies to address to improve patient care and clinical outcomes in NVAF.

Review the downloadable slideset and the full program at:
https://bit.ly/3yYXP8e

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Overview of SDOH in NVAF and CV-Related Outcomes

Thu, 26 May 2022 16:10:00 +0000

This podcast is the first in a series of 3 featuring an multidisciplinary panel of expert faculty addressing the impact of social determinants of health on NVAF and CV-related outcomes and strategies to overcome these disparities. In this episode, David S. Kountz, MD, provides a detailed explanation of the atrial fibrillation paradox and data on the impacts of SDOH on NVAF CV-related outcomes.

Review the downloadable slideset and the full program at:
https://bit.ly/3yYXP8e

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A Closer Look at RA Treatment: JAK Inhibitor Efficacy and Safety

Fri, 11 Dec 2020 22:30:00 +0000

In this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman interpret the latest safety and efficacy data for JAK inhibitors in RA, including the ORAL, BEACON, BEAM, SELECT, and FINCH series in

bDMARD-IR
MTX-IR
MTX naive

Also included is an in-depth discussion of JAK safety, including MACE and VTE, and use in the clinic including JAK cycling

Presenters:

Stanley B. Cohen, MD
Clinical Professor
Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director
Division of Rheumatology
Presbyterian Hospital
Co-Medical Director
Metroplex Clinical Research Center
Dallas, Texas

Sheetal Desai, MD, MSEd
Chief of Rheumatology
Program Director
University of California, Irvine
Irvine, California

Eric M. Ruderman, MD
Professor, Associate Chief
Division of Rheumatology
Northwestern University Feinberg School of Medicine
Clinical Practice Director
Northwestern Medical Group
Chicago, Illinois

Download the accompanying slides at:
https://bit.ly/37bm6cJ

See the interactive video at:
https://bit.ly/3oCOtpV

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A Closer Look at RA Treatment: Targeted DMARDs

Fri, 11 Dec 2020 22:30:00 +0000

In this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss the recent changes in rheumatoid arthritis treatment options, reviewing the landscape of targeted DMARDs and JAK inhibitors, including:

Kinase signaling
JAK inhibitor activity and signaling
JAK selectivity

Presenters:

Sheetal Desai, MD, MSEd
Chief of Rheumatology
Program Director
University of California, Irvine
Irvine, California

Download the accompanying slides at:
https://bit.ly/3447Gce

See the interactive video at:
https://bit.ly/3oCOtpV

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A Closer Look at RA Treatment: Treat-to-Target Using Shared Decision-Making

Fri, 11 Dec 2020 22:25:00 +0000

In this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss how to translate information on JAK inhibitors and other treatments for your patient population in the clinic, covering practical tips on using:

Treat-to-target approaches
Disease activity measures
Shared decision-making
Decision aids
Translating clinical trial evidence

Also included are the experts’ answers to questions from clinicians like you.

Sheetal Desai, MD, MSEd
Chief of Rheumatology
Program Director
University of California, Irvine
Irvine, California

Download the accompanying slides at:
https://bit.ly/3gHDE3s

See the interactive video at:
https://bit.ly/3oCOtpV

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Managing Weight in NAFLD/NASH

support@deceraclinical.com (Rotonya Carr MD) — Wed, 8 Jul 2020 20:13:13 +0000

What should our patients with NAFLD eat? Listen as expert hepatologist Rotonya Carr, MD, explores the evidence behind different diets in NAFLD/NASH.

Download the slides from this podcast at:
https://bit.ly/3gpzuMj

See more NASH topics at:
https://bit.ly/3ezkBq6

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

NASH Screening in Diabetes

support@deceraclinical.com (Brent A. Neuschwander-Tetri MD) — Tue, 7 Jul 2020 21:16:07 +0000

Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk, including:

Should We Screen for NASH?
- Role of obesity and type 2 diabetes mellitus
Cardiovascular Risk in NAFLD/NASH
How to Evaluate for NAFLD/NASH
- Biomarkers
- Imaging
- When/whom to biopsy?
Management in Multidisciplinary Settings

Download the slides from this podcast at:
https://bit.ly/2ZBvVvy

See more NASH topics at:
https://bit.ly/3ezkBq6

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Noninvasive Tests for NASH

support@deceraclinical.com (Stephen A. Harrison) — Tue, 7 Jul 2020 18:29:06 +0000

Hear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests in NASH, including their use in:
• Diagnosis of NASH patients with NAS ≥ 4 and fibrosis ≥ F2
• Assessment of therapeutic response
• Assessment of long-term patient outcomes

Download the slides from this podcast at:
https://bit.ly/3il5rqG

See more NASH topics at:
https://bit.ly/3ezkBq6

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Current NASH Treatments

support@deceraclinical.com (Philip N. Newsome PhD FRCPE) — Thu, 2 Jul 2020 17:31:13 +0000

Hear Philip N. Newsome, PhD, FRCPE, discussavailable approaches to managing NASH, including lifestyle, vitamin E, and compounds that target insulin resistance, including:

Recommended Pharmacologic Therapies for NASH
- Pioglitazone
- Vitamin E
Optimal Diabetes Therapies in NAFLD/NASH
- Weight Loss
- Liver Health
Surgical Approaches to Weight Loss and Effect on Liver

Download the slides from this podcast at:

https://bit.ly/3ig0r6x

See more NASH topics at:

https://bit.ly/3ezkBq6

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

New Developments in Gene Therapy for Muscular Dystrophy

support@deceraclinical.com (Kathryn R. Wagner MD, Richard S. Finkel MD) — Thu, 2 Jul 2020 17:30:22 +0000

Hear Dr. Katherine Wagner *and *Dr. Richard Finkle discussnovel gene-based approaches to treating patients with Duchenne muscular dystrophy and limb girdle muscular dystrophies. The latest clinical trial data and gene therapy considerations for product selection including AAV mini-dystrophin and other investigational therapies will be explored.

Download the slides from this podcast at:
https://bit.ly/2zZgB2X

See more neurology topics at:
https://bit.ly/3eAMVby

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Emerging NASH Treatments

support@deceraclinical.com (Philip N. Newsome PhD FRCPE) — Wed, 1 Jul 2020 18:49:08 +0000

Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis, including those in phase III such as:

Obeticholic acid
Cenicriviroc
Resmetirom
Aramchol

Download the slides from this podcast at:
https://bit.ly/3eJYKvW

See more NASH topics at:
https://bit.ly/3ezkBq6

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Role of the Diabetes Care and Education Specialist in CGM

Tue, 31 Mar 2020 17:35:11 +0000

Link to CME: Claim Credit - https://bit.ly/3dQPQwT .

Continuous glucose monitoring (CGM) is a great tool that improves clinical outcomes for people with diabetes; these individuals are often happy to get this new technology.

However, there can be some initial barriers that both people with diabetes and clinicians need to overcome.

BARRIER 1: Wearing something on the body so other people know the person has diabetes.

SOLUTION 1: Let the person see the size of different devices through demonstrations and show possible discreet places on the body where they can be worn.

Consider starting with a professional CGM, owned by the clinic and borrowed by the individual for up to 14 days, so that he or she can get a feel for what it is like.
Consider a CGM that can be integrated with a smart pen instead of an insulin pump, so the individual has only 1 device to wear.

BARRIER 2: Cost of the CGM.

SOLUTION 2: Find out insurance requirements to see if the CGM can be covered and what is required for coverage.

A disposable sensor is a lower cost option. There are coupons available and some pharmacies sell for lower costs.
Professional CGM is an underused insurance benefit that is often covered multiple times per year if used on a short- term basis.

BARRIER 3: Too much information from CGM can be overwhelming for the individual.

SOLUTION 3: Make sure alarms and alerts are set appropriately to avoid alarm fatigue—have the alerts go off when it matters most, like during hypoglycemia. Look at the device at key times only, like before meals, before bedtime, and before activities like exercising and driving, and utilize CGM to determine glycemic trends.

BARRIER 4: Clinicians are hesitant to embrace CGM technology.

SOLUTION 4: There are various resources available to help clinicians understand CGM technology and to assist in integrating CGM into their practice settings.

Online tutorials, industry representatives, and diabetes care and education specialists can help clinicians understand how to start people with diabetes on CGM and how to interpret the data.
CPT codes are now available to help support the cost of additional staff to train the individual on the devices and cover the cost of review and interpretation.

Presenters:
Carla Cox PhD, RD, FAADE
Certified Diabetes Educator and Clinical Dietitian
Mountain Vista Medicine
South Jordan, Utah

Diana Isaacs PharmD, BCPS, BCACP, BC-ADM, CDE
Clinical Pharmacy Specialist/CGM Program Coordinator
Department of Endocrinology, Diabetes, and Metabolism
Cleveland Clinic Diabetes Center
Cleveland, Ohio

Provided by the Endocrine Society in collaboration with the ADCES.
Supported by an educational grant from Lilly.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.